Interim Phase 3 analysis of the Oxford / AstraZeneca Covid-19 vaccine candidate showed a 70.4 percent efficacy in preventing the disease, Oxford University announced on Monday. At two different dosing regimens, the vaccine, AZD1222, was 90% and 62% effective. In the most effective dosing regimen, AZD1222 was administered as a …
Read More »How does Oxford Covid-19 vaccine, 70% effective, compare to Pfizer, Moderna? – world News
